Insights on the Pediatric Drugs and Vaccines Global Market to 2027 – Featuring Abbott Laboratories, Allergan and Amgen Among Others –

DUBLIN–(BUSINESS WIRE)–The report “Pediatric Drugs and Vaccines – Global Market Trajectory & Analytics” has been added to’s offer.

In the midst of the COVID-19 crisis, the global pediatric drug and vaccine market, estimated at US$100.1 billion by the year 2020, is expected to reach a revised size of US$148.8 billion by 2027, with a CAGR of 5.8% over the 2020-2027 analysis period.

Antibiotics, one of the segments analyzed in the report, is expected to achieve a CAGR of 5.9%, reaching $36.8 billion by the end of the analysis period. Following an early analysis of the business implications of the pandemic and the economic crisis caused, growth in the Vaccines segment is being revised to a revised CAGR of 6.8% for the next 7 years.

The US market is estimated at $27.1 billion, while China is expected to grow at 8.9% CAGR

The pediatric drug and vaccine market in the US is estimated to reach $27.1 billion by the year 2020. China, the world’s second largest economy, is expected to reach a projected market size of $31.4 billion by the year 2027. reaching a CAGR of 8.9% over the analysis period 2020 to 2027.

Other notable geographic markets include Japan and Canada, each of which is expected to grow by 3.2% and 5.2% respectively over the 2020-2027 period. Within Europe, Germany is expected to grow at approximately 3.7% CAGR.

Allergy and Respiratory Segment at 4.3% CAGR

In the global Allergy & Respiratory segment, the US, Canada, Japan, China and Europe will achieve the estimated CAGR of 3.9% for this segment. These regional markets, representing a combined market size of $14.1 billion by the year 2020, are projected to reach $18.4 billion by the end of the analysis period. China remains one of the fastest growing in this cluster of regional markets.

Led by countries such as Australia, India and South Korea, the Asia-Pacific market is projected to reach US$20.1 billion by the year 2027, while Latin America will grow at a CAGR of 5.3 during the analysis period. %.

Select competitors (total 90 recommended):

Abbott Laboratories Allergan Inc. Amgen Inc. AstraZeneca Plc Boehringer Ingelheim GmbH Bristol-Myers Squibb Company Eli Lilly and Company F. Hoffmann-La Roche Ltd Genentech Inc. GlaxoSmithKline Plc Janssen Biologics BV Merck & Co. Inc. Novartis AG Novo Nordisk A/S Pfizer Inc. Sanofi Shionogi Inc. Shire Pharmaceuticals Group Plc

Main topics covered:




Market Insights from Influencers Global Market Trajectories Pediatrics: A Highly Undervalued and Undervalued Group Recent Market Activity Pediatric Drugs Market – An Abode of Opportunity The United States: Largest Market for Pediatric Drugs and Vaccines Developing Markets to Witness Faster Growth Antibiotics: Top Selling Drug Classes Pediatric Vaccines Market – On fast-growing supply Dynamics of supply and demand of the global vaccine market UNICEF tackles shortage of BCG vaccine supply Access to vaccines Index: contributing to better access to vaccines Recent progress/results in the pediatric vaccines Space impact of Covid-19 and an imminent global recession



Pediatric exclusivity fuels manufacturers’ interest Pediatric exclusivity awarded to branded drugs New product approvals and pipeline – a key driver of growth Recent pediatric drug approvals: 2015-2017 Pediatric drug approvals: 2011-2014 Phase III Completed pediatric drug products: 2015-2017 (as of July 2017) Ongoing Phase III Pediatric Drugs Clinical Trials: 2015-2017 (as of July 2017) Potential for Pediatric Drugs for Obesity Related Disorders List of Pediatric Drugs for the Treatment of Congestive Heart Failure Recent Findings to Save Children’s Lives Challenges in Pediatric Drug Development: Formulation Challenges and Ethical Limitations of Clinical Trials Financial Temptation for Drug Manufacturers to Conduct Specialized Pediatric Trials Modeling and Simulation – A Force Pediatric Clinical Trials Tool Sponsors Pharmacometric Approaches Get Grip With US and EU Researchers Challenges Associated with Approval of Pharmacometric Approach Guidelines for Ethical Practice Correct Clinical Trials Pediatric Drug Market – Is Off Label Prescription Justifiable? Indian Drug Manufacturers Develop Pneumococcal Conjugate Vaccine High Vaccination Costs: A Major Obstacle to Pneumonia Vaccination Parental Vaccine Refusal – A Growing Trend in the US Market Orphan Drugs for Pediatric Use Gaining Popularity List of FDA Approved Orphan Drugs: 2015-2016 List of FDA Designated Orphan Drugs: 2015-2017 pediatric review vouchers promote innovation in rare pediatric drugs Need for greater focus on fixed-dose combinations for pediatric HIV infections Approved pediatric antiretroviral drugs for HIV treatment Highly fragmented growth hormone market




For more information on this report, visit

Comments are closed.